N-Nitroso Fluvoxamine EP Impurity K
N-Nitroso Fluvoxamine EP Impurity K is a specific impurity associated with the drug fluvoxamine, which is an antidepressant medication. In pharmaceutical contexts, impurities like N-Nitroso Fluvoxamine EP Impurity K are closely monitored because they can affect the efficacy, safety, and stability of the drug product.Pharmaceutical companies use analytical methods to monitor and control the levels of N-Nitroso Fluvoxamine EP Impurity K during the manufacturing process and in finished drug products.
N-Nitroso Fluvoxamine EP Impurity K CAS NO:NA also Known as N-Nitroso Fluvoxamine Impurity K chemically represented as (E)-N-(2-aminoethyl)-N-(2-(((1-(4-(trifluoromethyl)phenyl)pentylidene)amino)oxy)ethyl)nitrous amide. Synchemia is the leading manufacturing and exporter of N-Nitroso Fluvoxamine EP Impurity K . We supply N-Nitroso Fluvoxamine EP Impurity K with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143684 |
| CAS No | NA |
| Mol.F. | C22H29N3O6 |
| Mol.Wt. | 431.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143685 |
| CAS No | NA |
| Mol.F. | C24H33N3O6 |
| Mol.Wt. | 459.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143686 |
| CAS No | NA |
| Mol.F. | C23H31N3O6 |
| Mol.Wt. | 445.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143687 |
| CAS No | NA |
| Mol.F. | C23H31N3O6 |
| Mol.Wt. | 445.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143688 |
| CAS No | NA |
| Mol.F. | C23H31N3O6 |
| Mol.Wt. | 445.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143689 |
| CAS No | NA |
| Mol.F. | C23H31N3O6 |
| Mol.Wt. | 445.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143690 |
| CAS No | NA |
| Mol.F. | C15H18N2O3 : HCl |
| Mol.Wt. | 274.3 : 36.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143691 |
| CAS No | NA |
| Mol.F. | C12H13N3O4 |
| Mol.Wt. | 263.25 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143692 |
| CAS No | NA |
| Mol.F. | C7H9N5O |
| Mol.Wt. | 179.2 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143693 |
| CAS No | NA |
| Mol.F. | C19H15D4ClN4O7S |
| Mol.Wt. | 486.9 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143694 |
| CAS No | NA |
| Mol.F. | C21H26N4O3 |
| Mol.Wt. | 382.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143695 |
| CAS No | NA |
| Mol.F. | C12H9D3N2O |
| Mol.Wt. | 203.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143696 |
| CAS No | NA |
| Mol.F. | C15H23N5O3 |
| Mol.Wt. | 321.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143697 |
| CAS No | NA |
| Mol.F. | C10H15N5O |
| Mol.Wt. | 221.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143698 |
| CAS No | NA |
| Mol.F. | C10H15N5O |
| Mol.Wt. | 221.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143699 |
| CAS No | NA |
| Mol.F. | C10H14N6O2 |
| Mol.Wt. | 250.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |